AUTL - Autolus Therapeutics plc (AUTL) CEO Dr. Christian Itin on Q3 2021 Results - Earnings Call Transcript

Autolus Therapeutics plc (AUTL) Q3 2021 Earnings Conference Call November 3, 2021 08:30 AM ET Company Participants Dr. Lucinda Crabtree - Vice President of Business Planning and Strategy Dr. Christian Itin - Chief Executive Officer Christopher Vann - Chief Operating Officer Andrew Oakley - Chief Financial Officer Conference Call Participants Mara Goldstein - Mizuho Nishant Gandhi - Needham & Company Nick Abbott - Wells Fargo Asthika Goonewardene - Truist Securities Matt Phipps - William Blair Eric Joseph - JPMorgan Gil Blum - Needham & Company Presentation Operator Hello, ladies and gentlemen, and welcome to the Autolus Therapeutics Third Quarter 2021 Financial Results Conference Call. As a reminder, this conference call is being recorded. I would now like to turn the conference over to your host, Dr. Lucinda Crabtree, Vice President, Business Strategy. Please go ahead. Dr. Lucinda Crabtree Thank you, Daniel. Good morning or good afternoon, everyone, and thank you

For further details see:

Autolus Therapeutics plc (AUTL) CEO Dr. Christian Itin on Q3 2021 Results - Earnings Call Transcript